Medical Journals

Role of Oxidative Stress in Cardiac Dysfunction of Pparalpha-/- Mice.

Authors:
  • Guellich Aziz
  • Damy Thibaud
  • Lecarpentier Yves
  • Conti Marc
  • Claes Victor
  • Samuel Jane-Lyse
  • Quillard Jeanine
  • Hébert Jean-Louis
  • Pineau Thierry
  • Coirault Catherine

From: INSERM U689, Centre de Recherche Cardiovasculaire INSERM Lariboisière, 41 Boulevard de la Chapelle, 75475 Paris Cedex 10, France.

American journal of physiology. Heart and circulatory physiology

  • Publish Date: Jul 2007
  • ISSN: 0363-6135
  • Volume: 293
  • Issue: 1
  • Pages: H93-H102
  • Medium: Print
  • Language: English
  • Citation (JAMA): Guellich Aziz, Damy Thibaud, Lecarpentier Yves, et al. Role of Oxidative Stress in Cardiac Dysfunction of Pparalpha-/- Mice.. Am. J. Physiol. Heart Circ. Physiol. Jul 2007;293:H93-H102

Abstract

This study was designed to determine the effects of PPARalpha lack on cardiac mechanical performance and to identify potential intracellular mechanisms linking PPARalpha pathway deficiency to cardiac contractile dysfunction. Echocardiography, ex vivo papillary muscle assays, and in vitro motility assays were used to assess global, intrinsic ventricular muscle performance and myosin mechanical properties, respectively, in PPARalpha(-/-) and age-matched wild-type mice. Three-nitrotyrosine formation and 4-hydroxy-2-nonenal protein-adducts, both markers of oxidative damage, were analyzed by Western blot analysis and immunolabeling. Radical scavenging capacity was analyzed by measuring protein levels and/or activities of the main antioxidant enzymes, including catalase, glutathione peroxidase, and manganese and copper-zinc superoxide dismutases. Echocardiographic left ventricular fractional shortening in PPARalpha(-/-) was 16% lower than that in wild-type. Ex vivo left ventricular papillary muscle exhibited reduced shortening velocity and isometric tension (three- and twofold, respectively). In vitro myosin-based velocity was approximately 20% slower in PPARalpha(-/-), indicating that myosin itself was involved in the contractile dysfunction. Staining of 3-nitrotyrosine was more pronounced in PPARalpha(-/-), and myosin heavy chain was the main nitrated protein. Formation of 3-nitrotyrosine myosin heavy chain was twofold higher in PPARalpha(-/-) and 4-hydroxy-2-nonenal protein-adducts were threefold higher. The expression and activity of manganese superoxide dismutase were respectively 33% and 50% lower in PPARalpha(-/-), with no changes in copper-zinc superoxide dismutase, catalase, or glutathione peroxidase. These findings demonstrate that PPARalpha pathway deficiency impairs cardiac function and also identify oxidative damage to myosin as a link between PPARalpha deficiency and contractile dysfunction.

Mesh Headings (Keywords): Animals, Cytokines, Male, Mice, Mice, Knockout, Models, Cardiovascular, Myosins, Oxidative Stress, PPAR alpha, Reactive Oxygen Species, Ventricular Dysfunction, Left


Check for Full Text / PubMed Unique Identifier (PMID): 17369471


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.